-
Ab170834-5mgTeprotumumab (anti-IGF1R) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab (anti-IGF1R) binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab (anti-IGF1R) inhibits TSH and IGF-1 action in
-
Ab176617-100μgTesidolumab (anti-Complement C5) is a fully-human IgG1/λ anti-C5 monoclonal antibody. Tesidolumab (anti-Complement C5) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.Purity>95% (SDS-PAGE&SEC)Endotoxin
-
Ab176617-10mgTesidolumab (anti-Complement C5) is a fully-human IgG1/λ anti-C5 monoclonal antibody. Tesidolumab (anti-Complement C5) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.Purity>95% (SDS-PAGE&SEC)Endotoxin
-
Ab176617-1mgTesidolumab (anti-Complement C5) is a fully-human IgG1/λ anti-C5 monoclonal antibody. Tesidolumab (anti-Complement C5) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.Purity>95% (SDS-PAGE&SEC)Endotoxin
-
Ab176617-5mgTesidolumab (anti-Complement C5) is a fully-human IgG1/λ anti-C5 monoclonal antibody. Tesidolumab (anti-Complement C5) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.Purity>95% (SDS-PAGE&SEC)Endotoxin
-
Ab176555-100μgTesnatilimab (anti-NKG2D) is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab (anti-NKG2D) can be used in the study of inflammatory
-
Ab176555-10mgTesnatilimab (anti-NKG2D) is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab (anti-NKG2D) can be used in the study of inflammatory
-
Ab176555-1mgTesnatilimab (anti-NKG2D) is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab (anti-NKG2D) can be used in the study of inflammatory
-
Ab176555-5mgTesnatilimab (anti-NKG2D) is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab (anti-NKG2D) can be used in the study of inflammatory
-
Ab170833-100μgTezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab (anti-TSLP) can be used for the research of severe, uncontrolled
-
Ab170948-100μgTinurilimab (anti-CEACAM6) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab170948-10mgTinurilimab (anti-CEACAM6) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg